|
12th Congress of the European Hematology Association
|
|
|
|
Dr. E. Olavarria
|
| Search Tips: here are some examples |
| Abdominal obesity | Returns slides that contain AT LEAST ONE of the words |
| +Abdominal +obesity | Returns slides with BOTH words |
| +Abdominal -obesity | Returns slides with Abdominal ONLY and eliminates all slides with obesity |
| Cardio* | Returns slides with Cardio, Cardiology, Cardiovascular, etc. |
| "Abdominal obesity" | Returns only slides with this EXACT COMBINATION and order of words |
|
|
|
|
|
London, United Kingdom 
Imperial College London
Eduardo Olavarria, MD, PhD
Dr Eduardo Olavarria is the Medical Director of the Blood and Marrow Transplantation Unit at the Hammersmith Hospital, London, UK, and Honorary Senior Lecturer at the Department of Haematology, Imperial College London. He obtained his medical degree at the University of Navarre and a PhD degree from the Autonoma University in Madrid, Spain. He completed his training in haematology and stem cell transplantation between Madrid and London and worked as a clinical research fellow in the Royal Postgraduate Medical School in London.
Dr. Olavarria’s research interests focus on minimal residual disease in chronic myeloid leukemia, immunotherapy in allogeneic stem cell transplantation, the use of unrelated and haplo-identical donors for SCT, and infectious complications of stem cell transplantation.
|
|
| Presentations by Dr. E. Olavarria currently available on MultiWebcast.com |
12th Congress of the European Hematology Association
 |
Management of patients with imatinib resistance
2007-06-08 - English - Chronic Myeloid Leukemia
|
|
In summary the management of CML has been revolutionised by the introduction of TKI. The field continues to evolve rapidly and definitive statements regarding management are impossible. For those patients responding to imatinib the likelihood is that their disease will...(more) |
|
|
|
|
|
